blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1973887

EP1973887 - AZA HETEROCYCLICS FOR THE TREATMENT OF MALARIA OR AIDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.07.2013
Database last updated on 05.08.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
Immupharma France SA
Technopole 40 Rue Marc Seguin F-BP 2118
68060 Mulhouse Cedex / FR
[2008/40]
Inventor(s)01 / GILLES, Guichard
5, rue du Milieu
67202 Wolfisheim / FR
02 / LENA, Gersande
Hameau de Vaux
69840 Julienas / FR
03 / LALLEMAND, Eliette
5, rue du Poirier Fourrier
95100 Argenteuil / FR
04 / RENIA, Laurent
Zion Mansion
23 Holland Rik
Singapore 287811 / SG
 [2012/22]
Former [2008/40]01 / GILLES, Guichard
.
. / FR
02 / LENA, Gersande
.
. / FR
03 / LALLEMAND, Eliette
.
. / FR
04 / RENIA, Laurent
.
. / FR
Representative(s)Bauer, Wulf
Patentanwälte
Bauer Vorberg Kayser
Partnerschaft mbB
Goltsteinstrasse 87
50968 Köln / DE
[N/P]
Former [2012/38]Bauer, Wulf
Bauer Vorberg Kayser Patentanwälte Goltsteinstrasse 87
50968 Köln / DE
Former [2009/31]Bauer, Wulf
Bauer Vorberg Kayser Patentanwälte Lindenallee 43
50968 Köln (Marienburg) / DE
Former [2008/40]Bauer, Wulf
Bauer - Vorberg - Kayser Patentanwälte Lindenallee 43
50968 Köln / DE
Application number, filing date06841645.228.12.2006
[2008/40]
WO2006EP70258
Priority number, dateUS20050755631P29.12.2005         Original published format: US 755631 P
[2008/40]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007074171
Date:05.07.2007
Language:EN
[2007/27]
Type: A1 Application with search report 
No.:EP1973887
Date:01.10.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 05.07.2007 takes the place of the publication of the European patent application.
[2008/40]
Type: B1 Patent specification 
No.:EP1973887
Date:19.09.2012
Language:EN
[2012/38]
Search report(s)International search report - published on:EP05.07.2007
ClassificationIPC:C07D255/02, C07D273/02, C07D273/06, C07D285/38, A61K31/395, A61P31/18, A61P33/06
[2008/40]
CPC:
C07D255/02 (EP); A61P31/18 (EP); A61P33/06 (EP);
C07D273/02 (EP); C07D273/06 (EP); C07D285/38 (EP);
Y02A50/30 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/40]
TitleGerman:AZA-HETEROCYCLEN ZUR BEHANDLUNG VON MALARIA ODER AIDS[2008/40]
English:AZA HETEROCYCLICS FOR THE TREATMENT OF MALARIA OR AIDS[2008/40]
French:HETEROCYCLES AZA DESTINES AU TRAITEMENT DU PALUDISME OU DU SIDA[2008/40]
Entry into regional phase01.07.2008National basic fee paid 
01.07.2008Designation fee(s) paid 
01.07.2008Examination fee paid 
Examination procedure01.07.2008Examination requested  [2008/40]
08.06.2009Despatch of a communication from the examining division (Time limit: M04)
29.09.2009Reply to a communication from the examining division
24.11.2009Despatch of a communication from the examining division (Time limit: M06)
29.05.2010Reply to a communication from the examining division
15.10.2010Despatch of a communication from the examining division (Time limit: M06)
28.03.2011Reply to a communication from the examining division
19.05.2011Despatch of a communication from the examining division (Time limit: M06)
16.11.2011Reply to a communication from the examining division
02.05.2012Communication of intention to grant the patent
08.08.2012Fee for grant paid
08.08.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  08.06.2009
Opposition(s)20.06.2013No opposition filed within time limit [2013/35]
Fees paidRenewal fee
18.12.2008Renewal fee patent year 03
09.12.2009Renewal fee patent year 04
08.12.2010Renewal fee patent year 05
27.12.2011Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.12.2006
AT19.09.2012
BE19.09.2012
CY19.09.2012
CZ19.09.2012
DK19.09.2012
EE19.09.2012
FI19.09.2012
LT19.09.2012
LV19.09.2012
NL19.09.2012
PL19.09.2012
RO19.09.2012
SE19.09.2012
SI19.09.2012
SK19.09.2012
TR19.09.2012
BG19.12.2012
GR20.12.2012
IE28.12.2012
LU28.12.2012
ES30.12.2012
MC31.12.2012
IS19.01.2013
PT21.01.2013
[2014/34]
Former [2014/27]AT19.09.2012
BE19.09.2012
CY19.09.2012
CZ19.09.2012
DK19.09.2012
EE19.09.2012
FI19.09.2012
LT19.09.2012
LV19.09.2012
NL19.09.2012
PL19.09.2012
RO19.09.2012
SE19.09.2012
SI19.09.2012
SK19.09.2012
TR19.09.2012
BG19.12.2012
GR20.12.2012
IE28.12.2012
LU28.12.2012
ES30.12.2012
MC31.12.2012
IS19.01.2013
PT21.01.2013
Former [2014/21]AT19.09.2012
BE19.09.2012
CY19.09.2012
CZ19.09.2012
DK19.09.2012
EE19.09.2012
FI19.09.2012
LT19.09.2012
LV19.09.2012
NL19.09.2012
PL19.09.2012
RO19.09.2012
SE19.09.2012
SI19.09.2012
SK19.09.2012
TR19.09.2012
BG19.12.2012
GR20.12.2012
IE28.12.2012
ES30.12.2012
MC31.12.2012
IS19.01.2013
PT21.01.2013
Former [2013/47]AT19.09.2012
BE19.09.2012
CY19.09.2012
CZ19.09.2012
DK19.09.2012
EE19.09.2012
FI19.09.2012
LT19.09.2012
LV19.09.2012
NL19.09.2012
PL19.09.2012
RO19.09.2012
SE19.09.2012
SI19.09.2012
SK19.09.2012
BG19.12.2012
GR20.12.2012
IE28.12.2012
ES30.12.2012
MC31.12.2012
IS19.01.2013
PT21.01.2013
Former [2013/34]AT19.09.2012
BE19.09.2012
CY19.09.2012
CZ19.09.2012
DK19.09.2012
EE19.09.2012
FI19.09.2012
LT19.09.2012
LV19.09.2012
NL19.09.2012
PL19.09.2012
RO19.09.2012
SE19.09.2012
SI19.09.2012
SK19.09.2012
BG19.12.2012
GR20.12.2012
ES30.12.2012
MC31.12.2012
IS19.01.2013
PT21.01.2013
Former [2013/33]AT19.09.2012
BE19.09.2012
CY19.09.2012
CZ19.09.2012
EE19.09.2012
FI19.09.2012
LT19.09.2012
LV19.09.2012
NL19.09.2012
PL19.09.2012
RO19.09.2012
SE19.09.2012
SI19.09.2012
SK19.09.2012
GR20.12.2012
ES30.12.2012
MC31.12.2012
IS19.01.2013
PT21.01.2013
Former [2013/31]AT19.09.2012
BE19.09.2012
CY19.09.2012
CZ19.09.2012
EE19.09.2012
FI19.09.2012
LT19.09.2012
LV19.09.2012
NL19.09.2012
PL19.09.2012
RO19.09.2012
SE19.09.2012
SI19.09.2012
SK19.09.2012
GR20.12.2012
ES30.12.2012
IS19.01.2013
PT21.01.2013
Former [2013/28]BE19.09.2012
CY19.09.2012
CZ19.09.2012
EE19.09.2012
FI19.09.2012
LT19.09.2012
LV19.09.2012
NL19.09.2012
PL19.09.2012
RO19.09.2012
SE19.09.2012
SI19.09.2012
SK19.09.2012
GR20.12.2012
ES30.12.2012
IS19.01.2013
PT21.01.2013
Former [2013/23]BE19.09.2012
CY19.09.2012
CZ19.09.2012
EE19.09.2012
FI19.09.2012
LT19.09.2012
LV19.09.2012
NL19.09.2012
PL19.09.2012
RO19.09.2012
SE19.09.2012
SI19.09.2012
SK19.09.2012
GR20.12.2012
ES30.12.2012
IS19.01.2013
Former [2013/22]BE19.09.2012
CY19.09.2012
CZ19.09.2012
EE19.09.2012
FI19.09.2012
LT19.09.2012
LV19.09.2012
NL19.09.2012
SE19.09.2012
SI19.09.2012
GR20.12.2012
ES30.12.2012
IS19.01.2013
Former [2013/20]BE19.09.2012
CY19.09.2012
FI19.09.2012
LT19.09.2012
LV19.09.2012
SE19.09.2012
SI19.09.2012
GR20.12.2012
Former [2013/12]CY19.09.2012
FI19.09.2012
LT19.09.2012
LV19.09.2012
SE19.09.2012
SI19.09.2012
GR20.12.2012
Former [2013/11]CY19.09.2012
FI19.09.2012
LT19.09.2012
LV19.09.2012
SI19.09.2012
GR20.12.2012
Former [2013/10]CY19.09.2012
FI19.09.2012
LT19.09.2012
Former [2013/09]FI19.09.2012
LT19.09.2012
Former [2013/08]LT19.09.2012
Cited inInternational search[X]WO9309133  (SMITHKLINE BEECHAM CORP [US]) [X] 1,4 * claims 1,2 *;
 [A]WO9408977  (DU PONT MERCK PHARMA [US]) [A] 1-6* claim 1 *;
 [A]WO9502582  (CIBA GEIGY AG [CH], et al) [A] 1-6 * claim 1 *;
 [X]WO0190083  (HOFFMANN LA ROCHE [CH]) [X] 1,4 * claims 1,3 *;
 [X]WO0196318  (CENTRE NAT RECH SCIENT [FR], et al) [X] 1,4 * claims 14-16 *;
 [X]WO0228842  (NOVARTIS AG [CH], et al) [X] 1 * claims 1,2 *;
 [PX]  - LENA ET AL, "1,3,5-Triazepan-2,6-diones as structurally diverse and conformationally constrained dipeptide mimetics: identification of malaria liver stage inhibitors from a small pilot library", CHEMISTRY--A EUROPEAN JOURNAL, (20061115), vol. 12, no. 33, pages 8498 - 8512, XP002424879 [PX] 1-6 * page 8500; examples 4a,4l; table 1 *

DOI:   http://dx.doi.org/10.1002/chem.200600560
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.